PANACEA BIOTEC
Back to Income Statement
|
PANACEA BIOTEC Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹-8.37 Cr | ₹-1.17 Cr | ₹-33 Cr | ₹1,078 Cr | ₹-148 Cr |
What is the latest Consolidated Net Profit of PANACEA BIOTEC ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹-8.37 Cr |
| Mar2024 | ₹-1.17 Cr |
| Mar2023 | ₹-33 Cr |
| Mar2022 | ₹1,078 Cr |
| Mar2021 | ₹-148 Cr |
How is Consolidated Net Profit of PANACEA BIOTEC Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹-8.37 Cr | Negative | |
| Mar2024 | ₹-1.17 Cr | Negative | |
| Mar2023 | ₹-33 Cr | Negative | |
| Mar2022 | ₹1,078 Cr | Positive | |
| Mar2021 | ₹-148 Cr | - | |
Compare Consolidated Net Profit of peers of PANACEA BIOTEC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PANACEA BIOTEC | ₹2,227.6 Cr | 3% | 6.5% | -32.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,497.0 Cr | -1.4% | -6.2% | -1.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,939.0 Cr | -0.1% | 2.3% | 9.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,109.0 Cr | -1.8% | -4.9% | 28.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,578.0 Cr | -0.4% | -6% | 5.3% | Stock Analytics | |
| CIPLA | ₹99,761.1 Cr | 0.4% | -2.6% | -17.6% | Stock Analytics | |
PANACEA BIOTEC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PANACEA BIOTEC | 3% |
6.5% |
-32.1% |
| SENSEX | 0.5% |
3.2% |
2.3% |
You may also like the below Video Courses